PatientsLikeMe : Montelukast Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.

Patients

Taking Montelukast
38 Patients currently take Montelukast
5 Patients stopped taking Montelukast
thjuland Sensation: None Overall: Mild Cognition: moderate Vision: moderate Speech: mild Swallowing: none Upper limb: moderate Walking: moderate See profile thjuland Singulair, 10mg daily since Jun 11, 2007
dbrister Sensation: Moderate Overall: Mild Cognition: moderate Vision: moderate Speech: mild Swallowing: moderate Upper limb: moderate Walking: moderate See profile dbrister Singulair, 10mg daily since Jan 22, 2001
Papabear Sensation: Severe Overall: Severe Cognition: severe Vision: moderate Speech: severe Swallowing: severe Upper limb: severe Walking: severe See profile Papabear Singulair, 10mg daily since Mar 31, 2008

Brand Names: Azlaire, Singulair
Generic Name: Montelukast

What is Montelukast? Montelukast is in a class of medications called leukotriene receptor antagonists (LTRAs). It works by blocking the action of substances in the body that cause the symptoms of asthma and allergies. Read more...

See more information, including instructions, precautions, side effects, and interactions.

Jump to:: Reasons Taken; Dosages; Duration; Patient Evaluations

Reasons Taken

43 patients in the community are taking or have taken Montelukast.

Reason	# Patients	Percentage of patients
Other	35	81%
General health	4	9%
Asthma	1	2%
Don't know	1	2%

Dosages

Based on the patients currently taking Montelukast.

0 mg day	1 mg day	10 mg day	100 mg day
7	1	29	1

Duration

How long current patients have been taking Montelukast or how long patients were taking Montelukast before stopping.

Currently taking Montelukast

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
1	1	3	7	4	13

Stopped taking Montelukast

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	1	2	0	2

Why Patients Stopped Taking Montelukast (multiple reasons could be selected)
Reason	# Patients	Percentage of patients
Expense	2	40%
Did not seem to work	1	20%
Personal research	1	20%
Other	1	20%
Course of treatment ended	1	20%

Patient Reported Evaluations

Results from 3 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major	50%	1
Moderate	50%	1

Other

Side-effects (as an overall problem)

Severe	0%	0
Moderate	0%	0
Mild	0%	0
None	100%	3

Top reported side-effects include:

Summary results are based on 3 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 3)

dbrister

Sensation: Moderate

Overall: Mild

Cognition: moderate

Vision: moderate

Speech: mild

Swallowing: moderate

Upper limb: moderate

Walking: moderate

See profile
by dbrister
Sep 04, 2008